Brief: BioAtla Q3 Net Income USD -10.586 Million
07/11/2024 21:01
Nov 07 (Reuters) - BioAtla Q3 operating expenses USD 22.27 million. * Q3 operating income USD -11.27 million
Recent news on Bioatla
See all newsBrief: Context Therapeutics Enters Into License Agreement Amendment With BioAtla For CT-202
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM